Pages that link to "Q43612758"

The following pages link to Virologic outcome and predictors of virologic failure of highly active antiretroviral therapy containing protease inhibitors. (Q43612758):

Displaying 43 items.

• Telephone delivered interventions for reducing morbidity and mortality in people with HIV infection (Q24202803) (← links)
• Telephone delivered interventions for reducing morbidity and mortality in people with HIV infection (Q24234249) (← links)
• Patient support and education for promoting adherence to highly active antiretroviral therapy for HIV/AIDS (Q24245348) (← links)
• Risk factors for poor virological outcome at 12 months in a workplace-based antiretroviral therapy programme in South Africa: a cohort study (Q33352323) (← links)
• Randomized control trial of peer-delivered, modified directly observed therapy for HAART in Mozambique (Q33707611) (← links)
• Predictors of virologic response in persons who start antiretroviral therapy during recent HIV infection (Q33727042) (← links)
• Self-report measures of antiretroviral therapy adherence: A review with recommendations for HIV research and clinical management (Q33851716) (← links)
• HIV virological failure and drug resistance among injecting drug users receiving first-line ART in China (Q34365072) (← links)
• The information-motivation-behavioral skills model of ART adherence in a Deep South HIV clinic sample (Q34480139) (← links)
• Cost-effectiveness of a nurse-based intervention (AIMS) to improve adherence among HIV-infected patients: design of a multi-centre randomised controlled trial (Q34995331) (← links)
• HIV viral suppression in the era of antiretroviral therapy (Q35059337) (← links)
• Update on the Virologic and Immunologic Response to Highly Active Antiretroviral Therapy (Q35841783) (← links)
• A proposal for quality standards for measuring medication adherence in research (Q36210156) (← links)
• Baseline medication adherence and response to an electronically delivered health literacy intervention targeting adherence (Q36503634) (← links)
• Predictors of antiretroviral treatment failure in an urban HIV clinic (Q36628011) (← links)
• Superior Effects of Antiretroviral Treatment among Men Who have Sex with Men Compared to Other HIV At-Risk Populations in a Large Cohort Study in Hunan, China (Q36732366) (← links)
• Cohort profile: the Centers for AIDS Research Network of Integrated Clinical Systems (Q37002118) (← links)
• Assessing antiretroviral adherence via electronic drug monitoring and self-report: an examination of key methodological issues (Q37395005) (← links)
• Nine-year follow-up of HIV-infected Romanian children and adolescents receiving lopinavir/ritonavir-containing highly active antiretroviral therapy. (Q37441637) (← links)
• Modelling the evolution of HIV-1 virulence in response to imperfect therapy and prophylaxis (Q37661125) (← links)
• Nurse-led interventions to enhance adherence to chronic medication: systematic review and meta-analysis of randomised controlled trials (Q38050935) (← links)
• A simple self-reported adherence tool as a predictor of viral rebound in people with viral suppression on antiretroviral therapy (Q40724324) (← links)
• HIV care and general internal medicine: the next generation (Q42347084) (← links)
• Prospective Comparison of First-Line Nelfinavir Therapy versus Nelfinavir Introduction in Rescue Antiretroviral Regimens (Q42598306) (← links)
• Adherence to antiretroviral therapy and its impact on clinical outcome in HIV-infected patients (Q43260037) (← links)
• Factors predicting lack of adherence to highly active antiretroviral treatment (Q44217442) (← links)
• Correlates of HAART adherence among immigrant Latinos in the Southeastern United States (Q44312643) (← links)
• Strategies to optimize adherence to antiretroviral treatment. Interventions in the therapeutic regimen (Q44442989) (← links)
• Sleep disturbance and depression as barriers to adherence (Q44526140) (← links)
• Posttraumatic stress disorder symptoms, salivary cortisol, medication adherence, and CD4 levels in HIV-positive individuals (Q44693769) (← links)
• Determinants of long-term highly active antiretroviral treatment efficacy (Q44734013) (← links)
• An evaluation of the impact of a community-based adherence support programme on ART outcomes in selected government HIV treatment sites in South Africa. (Q44937706) (← links)
• Changes in stress, substance use and medication beliefs are associated with changes in adherence to HIV antiretroviral therapy (Q45195969) (← links)
• Comorbid conditions, treatment, and health maintenance in older persons with human immunodeficiency virus infection in New York City (Q45730280) (← links)
• Prediction of adherence to antiretroviral therapy: a one-year longitudinal study (Q48480671) (← links)
• Reframing HIV adherence as part of the experience of illness (Q50111278) (← links)
• Quality of life in HIV-infected individuals receiving antiretroviral therapy is related to adherence (Q51931076) (← links)
• Pharmacy care perspectives on problems with HIV antiretroviral therapy in Sweden. (Q51992918) (← links)
• Status and associated factors of self-management in people living with HIV/AIDS in Liangshan area, China: a cross-sectional study. (Q64921634) (← links)
• [How and why should adherence to antiretroviral therapy] (Q78518588) (← links)
• [Factors predicting detectable viral load in patients with highly active antiretroviral treatment] (Q80260776) (← links)
• Virologic and immunologic response to highly active antiretroviral therapy (Q81037629) (← links)
• Relationship of race-, sexual orientation-, and HIV-related discrimination with adherence to HIV treatment: a pilot study (Q81825627) (← links)